News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Nicholas Wade, New York Times | 12.10.2011
Medical researchers in Britain have successfully treated six patients suffering from the blood-clotting disease known as hemophilia B by injecting...
By Kim Severson, New York Times | 12.09.2011
LINWOOD, N.C. — Charles Holt, 62, spreads a cache of vintage government records across his trailer floor. They are the...
By Kim Severson, New York Times | 12.09.2011
LINWOOD, N.C. — Charles Holt, 62, spreads a cache of vintage government records across his trailer floor. They are the...
By Steve Johnson, San Jose Mercury News | 12.08.2011
Touted seven years ago as a way to develop "breakthrough cures" for an array of life-threatening ailments, California's $3 billion...
By Steve Johnson, San Jose Mercury News | 12.08.2011
Touted seven years ago as a way to develop "breakthrough cures" for an array of life-threatening ailments, California's $3 billion...
By Karen Barlow, ABC News [Australia] | 12.08.2011

The fight over human genes and whether they can be patented for medical research has gone to the US Supreme...

By Karen Barlow, ABC News [Australia] | 12.08.2011

The fight over human genes and whether they can be patented for medical research has gone to the US Supreme...

By Michael Hiltzik, Los Angeles Times | 12.07.2011

For years, Geron Corp. had claimed to be in the vanguard among California companies engaged in stem cell research. So...